Daiichi Sankyo Selects Veeva CRM to Support Customer Engagement Initiatives in the United Kingdom

By Veeva Systems And Daiichi Sankyo, PRNE
Monday, July 25, 2011

BARCELONA, Spain and GERRARDS CROSS, England, July 26, 2011 -

Veeva Systems announced today that Daiichi Sankyo, one of the
world’s top 20 pharmaceutical companies, is replacing its legacy,
on-premise Customer Relationship Management (CRM) system with Veeva
CRM in the UK. Daiichi Sankyo will deploy Veeva CRM to all of its
commercial teams in the UK including integrated healthcare,
specialty care, medical liaison scientists, and head-office teams
(i.e., marketing and medical) to drive more effective customer

Daiichi Sankyo had outgrown its current CRM system, according to
executives. “Most of our customer-facing teams were only using the
system as a basic customer information repository,” said Dr. Simon
, managing director for Daiichi Sankyo UK. “It lacked
important functionality and so became nothing more than an
expensive database to record calls. We were looking for a system
that offered functionality well beyond just call recording.”

After researching alternative CRM systems, Daiichi Sankyo
decided on Veeva CRM. “We’re all about innovation that leads to
enhanced quality and value for our customers,” said Clough. “We’ve
adopted an innovative agenda for advancing everything from our
science to our interactions with stakeholders, and Veeva CRM
supports it perfectly. The system’s intuitive, easy-to-use
interface and rich functionality are part of our strategy for
strengthening customer engagements in the UK’s changing NHS

Daiichi Sankyo was also drawn to Veeva iRep, which is the first
integrated Pharma CRM and CLM solution designed for the Apple iPad.
Clough continued, “We recognised that the system’s closed-loop
marketing functions and the device’s beautiful presentation of
multi-media content would support more interactive customer
engagements. With iRep, we expect that our account specialists will
be more connected, responsive, and effective.”  

Veeva Systems has rapidly become the leading provider of Pharma
CRM solutions globally. Cloud-based, Veeva CRM requires no hardware
or software to purchase, scale or maintain. In addition, all Veeva
customers benefit from free, automatic upgrades so users are always
on the most up-to-date version of the software and benefit from the
very latest compliance changes and system enhancements. Changes can
be made to the system instantly without user retraining or
additional third-party costs.

Bill Barone, head of learning & innovation at Daiichi Sankyo
UK concluded, “We are very excited to work with a pioneering CRM
organisation. Veeva is ahead of the curve and leading the market
from an innovation perspective.”

About Daiichi Sankyo

The Daiichi Sankyo Group is dedicated to the creation and supply
of innovative pharmaceutical products to address the diversified,
unmet medical needs of patients in both mature and emerging
markets. The company was created in 2005 through the merger of two
traditional Japanese enterprises, Daiichi and Sankyo. With net
sales of nearly €7.3 billion, Daiichi Sankyo is one of the world’s
20 leading pharmaceutical companies. While maintaining its
portfolio of marketed pharmaceuticals for hypertension,
hyperlipidemia, and bacterial infections, the Group is engaged in
the development of treatments for thrombotic disorders and focused
on the discovery of novel oncology and cardiovascular-metabolic
therapies. Furthermore, the Daiichi Sankyo Group has created a
“Hybrid Business Model”, which will respond to market and customer
diversity and optimize growth opportunities across the value

The company’s world headquarters are in Tokyo. Its European base
is located in Munich. Daiichi Sankyo Europe has affiliates in 12
European countries in addition to a global manufacturing site
located in Pfaffenhofen, Germany. For more information, please
visit: href="www.daiichisankyo.com/">www.daiichisankyo.com
or href="www.daiichi-sankyo.eu/">www.daiichi-sankyo.eu

About Veeva CRM
The Veeva CRM suite of applications, comprised of VBioPharma, iRep,
VMobile, and VInsights, is the pharmaceutical and biotechnology
industry’s leading cloud-based CRM solution. In addition, iRep has
quickly become the industry’s choice for closed loop marketing on
the iPad. Only Veeva CRM accommodates the unique needs of multiple
commercial teams in a single solution, improving user adoption and
sales effectiveness, while reducing cost and complexity. Veeva CRM
is now the foundation on which the pharmaceutical industry is
innovating its sales and marketing models for the future.

About Veeva Systems
Veeva Systems is the leader in cloud-based solutions for the global
life sciences industry. Committed to innovation, product
excellence, and customer success, Veeva has over 90 customers,
ranging from the world’s largest pharmaceutical companies to
emerging biotechs. Founded in 2007, Veeva is a privately held
company headquartered in the San Francisco Bay Area, with offices
in Philadelphia, Barcelona, Paris, Beijing, Shanghai, and Tokyo.
For more information, visit www.veevasystems.com.

Copyright (c) 2011 Veeva Systems. All rights reserved. Veeva and
the Veeva logo are registered trademarks of Veeva Systems. Veeva
Systems owns other registered and unregistered trademarks. Other
names used herein may be trademarks of their respective owners.

Media Contact

Selma Nawaz
European Marketing Director
Veeva Systems    

Jo Taylor
Communications Director
Daiichi Sankyo

Selma Nawaz, +34-93-187-0200; Jo Taylor, +44-1753-893-600

Pharmaceuticals News

England News

will not be displayed